Nplate 250 MCG vials
Ended Awarded
- Contract number
- SPE2DB25FYQ21
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,695
Award facts
- Contract value 100% obligated
- $6,694.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,694.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 250 microgram vials of Nplate. The contract was awarded on September 22, 2025, with an ultimate completion date of October 14, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA's SPE2DB program, a $499,999,999 vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense medical facilities.
Nplate (romiplostim) is a thrombopoietin receptor agonist used to treat thrombocytopenia, making this procurement consistent with DMS Pharmaceutical Group's established role as a critical supplier of specialty medications and biologics to military healthcare systems. The company has demonstrated sustained success in competing for pharmaceutical delivery orders with DLA across diverse product categories, from oncology treatments to vaccines and injectable medications. This award reflects the vendor's strategic positioning within the federal pharmaceutical supply chain and its ability to deliver specialized medical products to support DoD healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FYQ21?
SPE2DB25FYQ21 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FYQ21 worth?
The government has obligated $6,695 on SPE2DB25FYQ21.
Is contract SPE2DB25FYQ21 an order under another contract?
Yes. SPE2DB25FYQ21 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYQ21 competed?
The extent of competition for SPE2DB25FYQ21 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award